iScience (Jul 2022)

Uncoupling protein 2 and aldolase B impact insulin release by modulating mitochondrial function and Ca2+ release from the ER

  • Ryota Inoue,
  • Takahiro Tsuno,
  • Yu Togashi,
  • Tomoko Okuyama,
  • Aoi Sato,
  • Kuniyuki Nishiyama,
  • Mayu Kyohara,
  • Jinghe Li,
  • Setsuko Fukushima,
  • Tatsuya Kin,
  • Daisuke Miyashita,
  • Yusuke Shiba,
  • Yoshitoshi Atobe,
  • Hiroshi Kiyonari,
  • Kana Bando,
  • A.M. James Shapiro,
  • Kengo Funakoshi,
  • Rohit N. Kulkarni,
  • Yasuo Terauchi,
  • Jun Shirakawa

Journal volume & issue
Vol. 25, no. 7
p. 104603

Abstract

Read online

Summary: Uncoupling protein 2 (UCP2), a mitochondrial protein, is known to be upregulated in pancreatic islets of patients with type 2 diabetes (T2DM); however, the pathological significance of this increase in UCP2 expression is unclear. In this study, we highlight the molecular link between the increase in UCP2 expression in β-cells and β-cell failure by using genetically engineered mice and human islets. β-cell-specific UCP2-overexpressing transgenic mice (βUCP2Tg) exhibited glucose intolerance and a reduction in insulin secretion. Decreased mitochondrial function and increased aldolase B (AldB) expression through oxidative-stress-mediated pathway were observed in βUCP2Tg islets. AldB, a glycolytic enzyme, was associated with reduced insulin secretion via mitochondrial dysfunction and impaired calcium release from the endoplasmic reticulum (ER). Taken together, our findings provide a new mechanism of β-cell dysfunction by UCP2 and AldB. Targeting the UCP2/AldB axis is a promising approach for the recovery of β-cell function.

Keywords